Unipol Gruppo Valuation
Is UNI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of UNI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: UNI (€11.78) is trading below our estimate of fair value (€17.91)
Significantly Below Fair Value: UNI is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for UNI?
Key metric: As UNI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is UNI's PE Ratio? | |
|---|---|
| PE Ratio | 7.1x |
| Earnings | €1.20b |
| Market Cap | €8.45b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | 4.4x |
| PEG Ratio | 1.4x |
Price to Earnings Ratio vs Peers
How does UNI's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.6x | ||
VIG Vienna Insurance Group | 6.7x | 8.6% | €3.7b |
UQA UNIQA Insurance Group | 6.3x | -1.7% | €2.3b |
HELN Helvetia Holding | 29.8x | 14.3% | CHF 8.1b |
PZU Powszechny Zaklad Ubezpieczen | 7.5x | 1.4% | zł37.4b |
UNI Unipol Gruppo | 7.1x | 4.9% | €8.5b |
Price-To-Earnings vs Peers: UNI is good value based on its Price-To-Earnings Ratio (7.1x) compared to the peer average (12.6x).
Price to Earnings Ratio vs Industry
How does UNI's PE Ratio compare vs other companies in the European Insurance Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: UNI is good value based on its Price-To-Earnings Ratio (7.1x) compared to the European Insurance industry average (11.9x).
Price to Earnings Ratio vs Fair Ratio
What is UNI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 7.1x |
| Fair PE Ratio | 5.3x |
Price-To-Earnings vs Fair Ratio: UNI is expensive based on its Price-To-Earnings Ratio (7.1x) compared to the estimated Fair Price-To-Earnings Ratio (5.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €11.78 | €12.94 +9.8% | 4.5% | €13.60 | €12.00 | n/a | 5 |
| Nov ’25 | €11.54 | €11.40 -1.2% | 8.4% | €13.20 | €10.50 | n/a | 5 |
| Oct ’25 | €10.67 | €11.00 +3.1% | 3.1% | €11.50 | €10.50 | n/a | 5 |
| Sep ’25 | €9.60 | €10.68 +11.3% | 6.8% | €11.50 | €9.40 | n/a | 5 |
| Aug ’25 | €9.73 | €10.40 +6.9% | 6.5% | €11.50 | €9.40 | n/a | 5 |
| Jul ’25 | €9.45 | €10.40 +10.1% | 6.5% | €11.50 | €9.40 | n/a | 5 |
| Jun ’25 | €9.58 | €10.06 +5.1% | 8.8% | €11.50 | €8.90 | n/a | 5 |
| May ’25 | €8.50 | €8.72 +2.6% | 5.3% | €9.40 | €8.00 | n/a | 5 |
| Apr ’25 | €7.76 | €8.30 +6.9% | 7.1% | €8.90 | €7.30 | n/a | 5 |
| Mar ’25 | €7.47 | €8.30 +11.1% | 7.1% | €8.90 | €7.30 | n/a | 5 |
| Feb ’25 | €5.77 | €6.70 +16.2% | 10.1% | €7.50 | €5.80 | n/a | 5 |
| Jan ’25 | €5.17 | €6.70 +29.6% | 10.1% | €7.50 | €5.80 | n/a | 5 |
| Dec ’24 | €5.28 | €6.70 +26.8% | 10.1% | €7.50 | €5.80 | n/a | 5 |
| Nov ’24 | €5.14 | €6.80 +32.4% | 8.6% | €7.20 | €5.80 | €11.54 | 4 |
| Oct ’24 | €5.14 | €6.85 +33.2% | 9.1% | €7.40 | €5.80 | €10.67 | 4 |
| Sep ’24 | €5.16 | €6.62 +28.2% | 9.3% | €7.40 | €5.80 | €9.60 | 5 |
| Aug ’24 | €5.09 | €6.58 +29.2% | 9.1% | €7.40 | €5.80 | €9.73 | 5 |
| Jul ’24 | €4.90 | €6.58 +34.3% | 9.1% | €7.40 | €5.80 | €9.45 | 5 |
| Jun ’24 | €4.70 | €6.34 +35.1% | 12.1% | €7.40 | €5.15 | €9.58 | 6 |
| May ’24 | €5.14 | €6.33 +23.1% | 12.0% | €7.40 | €5.15 | €8.50 | 6 |
| Apr ’24 | €4.79 | €6.23 +30.0% | 13.2% | €7.40 | €4.86 | €7.76 | 6 |
| Mar ’24 | €5.01 | €6.11 +21.9% | 13.4% | €7.40 | €4.86 | €7.47 | 7 |
| Feb ’24 | €4.91 | €5.97 +21.4% | 12.7% | €7.00 | €4.86 | €5.77 | 7 |
| Jan ’24 | €4.59 | €5.97 +30.0% | 12.7% | €7.00 | €4.86 | €5.17 | 7 |
| Dec ’23 | €4.83 | €5.90 +22.2% | 12.3% | €7.00 | €4.90 | €5.28 | 8 |
| Nov ’23 | €4.42 | €5.86 +32.8% | 16.2% | €7.00 | €4.60 | €5.14 | 8 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Ping An Insurance (Group) Company of China
CN¥875.1b
Ping An Insurance (Group) Company of China, Ltd.
PZX
CN¥5.49
7D
-1.5%
1Y
19.9%
SCOR
€4.2b
Provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and Asia Pacific.
SCR
€23.70
7D
1.2%
1Y
n/a
ageas
€8.9b
Engages in insurance business.
AGS
€48.62
7D
0.04%
1Y
21.5%